|Articles|January 22, 2019

Current, New, and Emerging Therapies for the Prevention and Management of Migraine

https://www.pharmacytimes.org/on-demand/an-american-journal-of-managed-care-ajmc-2part-supplement-current-new-and-emerging-therapies-for-the-prevention-and-management-of-migraine

https://www.pharmacytimes.org/on-demand/an-american-journal-of-managed-care-ajmc-2part-supplement-current-new-and-emerging-therapies-for-the-prevention-and-management-of-migraine?rel=0" ?rel=0"

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Trending on AJMC

Current, New, and Emerging Therapies for the Prevention and Management of Migraine

Related Content

New Data Support Pimicotinib as Durable for Rare Tenosynovial Giant Cell Tumor

Surgery for Diabetic Gastroparesis May Improve HbA1c and Reduce Complications

Acoramidis Shows Durable Benefit at 54 Months in ATTR-CM

What Managed Care Should Watch at ADA 2026 Scientific Sessions

Odronextamab Plus CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Matthew Matasar, MD

Trending on AJMC

Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home

Rituximab Suppresses Clinical Relapses, MRI Activity in Pediatric MS

FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301

New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease

Cancer’s Hidden Wound: Trauma From Diagnosis Through Survivorship